Carlos Garcia-Echeverria

This inventor holds 12 USPTO granted patents and 23 published patent applications, plus 5 CIPO patents and 14 EPO patents. Top assignees: Novartis Ag, Cancer Research Campaign Technology Limited, Dana-Farber-Cancer Institute Inc.. Active years: 2006-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos Garcia-Echeverria. Retrieved from https://idiyas.com/inventor/carlos-garcia-echeverria

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 23)

% Patents Active = 58.3

CIPO Patents = 5

EPO Patents = 14 (Patent Applications = 15)

Average Co-Inventor Count = 4.5

ph-index = 9

Forward Citations = 298(Granted Patents)

Location History:

Basel, CH (2006 - 2016)
Saint-Cloud, FR (2012 - 2016)

Company Filing History:

Cancer Research Campaign Technology Limited

patents

1 out of 1,269

Dana-Farber-Cancer Institute Inc.

5. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2016

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9370508 - Imidazoquinolines as dual lipid kinase and mTOR inhibitors (2016-06-21),

2. 9241939 - Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathway (2016-01-26),

3. 9084781 - MEK mutations conferring resistance to MEK inhibitors (2015-07-21),

4. 8431592 - 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase inhibitors (2013-04-30),

5. 8263590 - Pyrimidine derivatives (2012-09-11),

6. 7998972 - 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases (2011-08-16),

7. 7994170 - 1,3-dihydro-imidazo[4,5-C]quinolin-2-ones as lipid kinase inhibitors (2011-08-09),

8. 7964592 - 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders (2011-06-21),

9. 7893074 - 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders (2011-02-22),

10. 7667039 - 1,3-dihydro-imidazo [4,5-C] quinolin-2-ones as lipid kinase inhibitors (2010-02-23),

11. 7326699 - 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives (2008-02-05),

12. 7083983 - Inhibitors of the interaction between P53 and MDM2 (2006-08-01),

Title: The Innovative Journey of Inventor Carlos Garcia-Echeverria

Introduction: Carlos Garcia-Echeverria is a visionary inventor based in Basel, Switzerland, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Carlos Garcia-Echeverria holds several patents in the areas of artificial intelligence, biotechnology, and renewable energy, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Carlos Garcia-Echeverria has worked with leading research institutions and multinational companies, spearheading projects that have revolutionized various industries.

Collaborations: Throughout his career, Carlos Garcia-Echeverria has collaborated with top universities, research institutions, and forward-thinking companies, fostering a culture of innovation and driving progress in the global technological landscape.

Conclusion: Carlos Garcia-Echeverria's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire future generations of inventors and innovators worldwide.

Profile summary based on public USPTO records.